are glp 1 drugs dangerous GLP-1 Medications: Everything You Need to Know Do The Benefits of GLP-1

Lilly has noted supply pressures for its incretin products

But over the last few years a class of medicines originally developed to treat type 2 diabetes has shown dramatic effects on body weight

Wegovy is a weight loss drug with the active ingredient semaglutide

However, it has since been shown that -arrestins can also function to activate signalling cascades 9,10

Semaglutide titration: 0.25mg to 2.4mg The semaglutide titration schedule moves through five dose levels over approximately 16-20 weeks: Weeks 1-4: 0.25mg weekly Weeks 5-8: 0.5mg weekly Weeks 9-12: 1.0mg weekly Weeks 13-16: 1.7mg weekly Week 17 onward: 2.4mg weekly (maintenance dose) Each increase happens monthly

January 2026: Now that the JPML has approved centralization of Wegovy and other GLP-1 NAION (vision loss) lawsuits, the Judge overseeing the litigation is likely preparing for the first stages of the MDL